<DOC>
	<DOCNO>NCT00594425</DOCNO>
	<brief_summary>This multicenter study divide 2 phase . The first phase open label , dose-escalation phase , second blind , randomize , vehicle-controlled , parallel-group , dose-response phase . The second phase start first phase succeed establish well tolerate dose ( ) . Patients moderate severe acne vulgaris face included.The result part 2 present result section .</brief_summary>
	<brief_title>Photodynamic Therapy ( PDT ) With Methyl Aminolevulinate ( MAL ) Cream Moderate Severe Acne</brief_title>
	<detailed_description>For second part : All patient receive 4 PDT session 2 week apart use light dose 37 J/cm2 . One treatment group receive vehicle cream , 2 group receive MAL cream concentration 40 mg/g 80 mg/g , respectively . The MAL vehicle cream apply thin layer clean skin leave 1.5 hour occlusion illumination .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<criteria>1 . Female male patient , age 15 40 year moderate severe facial acne vulgaris ( IGA score 34 ) . 2 . Patients skin type I IV ( Fitzpatrick ) . 3 . Patients 20 100 inflammatory lesion ( papule , pustule , nodule ) face exclude lesion nose periocular area . 4 . Patients 200 noninflammatory lesion ( open close comedo ) face . 5 . Patients 2 nodular lesion face . 6 . Patients surgically sterile , postmenopausal , abstinent , willing use adequate mean contraception include birth control pill , barrier method spermicide least 14 day prior Day 0 . Patients use birth control pill must use product dose least 6 month must agree stay product dose additional 6 month . 7 . Patients must willing capable follow study instruction extent degree require protocol . 8 . Patients must sign approve informed consent form prior study procedure . 9 . Patients must willing photograph . Patients must willing sign photography consent form . 1 . Known allergy MAL , similar PDT compound , excipients cream . 2 . Participation clinical study either concurrently within last 30 day . 3 . Patients condition situation , , investigator 's opinion , may put patient risk , may confound study result , may interfere patient 's participation study . 4 . Clinically significant sensitivity visible light , porphyria porphyrin sensitivity . 5 . Exposure ultraviolet radiation ( UVB phototherapy , sun tan salon ) within last 30 day . 6 . Patients washout period topical treatment acne less 14 day . Medicated cleanser may use washout period stop treatment . 7 . Patients washout period oral antibiotic treatment acne less 1 month . 8 . Patients washout period oral isotretinoin le 6 month . 9 . Patients beard facial hair might interfere study assessment .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>